Anti-TNFRSF5 / CD40 Reference Antibody (selicrelumab)
产品介绍
Selicrelumab通过诱导肿瘤微环境变化，可用于胰腺癌及肿瘤新辅助疗法的研究。
产品性质
产品特色
应用案例
Purity:SDS-PAGE
Anti-TNFRSF5 / CD40 Reference Antibody (selicrelumab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
Purity:SEC-HPLC
The purity of Anti-TNFRSF5 / CD40 Reference Antibody (selicrelumab) is more than 95%, determined by SEC-HPLC.
Bioactivity:ELISA
Immobilized human CD40 His at 2 ug/mL can bind Anti-TNFRSF5 / CD40 Reference Antibody (selicrelumab), EC50=0.009782 ug/mL.
存储条件
-25~-15℃保存，有效期1年。
COA
相关产品
联系我们
